Brolucizumab-dbll injection is used to treat neovascular (wet) age-related macular degeneration (AMD). Reference standards of Brolucizumab API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Brolucizumab - API Standards [catalogue_number] => PA 02 2500000 [category_ids] => ,78,70,82,76, [chemical_name] => [weight] => NA [form] => NA [cas] => 1531589-13-5 [pslug] => 1531589-13-5-brolucizumab-api-pa022500000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 2500000
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....